Stockreport

BRIEF-Spero Therapeutics Q3 Loss Per Share $36.02 [Reuters]

Spero Therapeutics, Inc.  (SPRO) 
Last spero therapeutics, inc. earnings: 3/16 08:45 am Check Earnings Report
US:NASDAQ Investor Relations: investors.sperotherapeutics.com/overview
PDF BRIEF-Spero Therapeutics Q3 Loss Per Share $36.02 | Reuters Reuters Staff 1 Min Read Dec 14 (Reuters) - Spero Therapeutics Inc: * SPERO THERAPEUTICS ANNOUNCES 3Q17 OPERA [Read more]